Dr. Attila Endre Pavlath Joins the Board of Directors of ComInnex Inc.
News Aug 09, 2014
ComInnex, Inc. has announced that Dr. Attila Endre Pavlath joined its Board of Directors.
Dr. Attila Endre Pavlath, a well known scientist and former ACS president will bring his strategic experience into the governing body of ComInnex. Dr. Pavlath’s 6 decades of achievements are also recognized by the American Chemical Society at a dedicated session at the ACS 248th National Meeting & Exposition in San Francisco on August 12th , 2014 at 8:00 am. (ww.acs.org).
ComInnex is a chemistry and medicinal chemistry service organization with strong interest and background in the development of chemical technologies that enables its partners to access novel chemical space and intellectual property. Its current technology innovation platform focuses on the development of synthetic tools towards novel non-flat fragment-like and lead-like molecules for lead identification and medicinal chemistry. To this end the company recently introduced its Smartdiversity™ platform that rapidly creates new IP space for medicinal chemistry.
ComInnex technologies enable the company to penetrate chemical space not easily reachable by traditional laboratory techniques and develop unique and patentable molecular frameworks of high value for the pharmaceutical, agrochemical and chemical industries.
Dr. Ferenc Darvas, President and Chairman of ComInnex commented that “We are proud that Dr. Pavlath joins our Governing Board. We believe that his experience and significant
achievements will be a great asset for the company and will help expand our value added innovative portfolio of offerings.”
Dr. Pavlath added that “I am glad that I could join such a dynamic and innovative company like ComInnex at the governing level and join the experienced industry veterans in the management and Board level such as Dr. Ferenc Darvas, Dr. Gergely Makara and Dr. Laszlo Urge. I believe that together we will create and execute a strategy that will benefit customers significantly and keep ComInnex in the forefront of innovation.”
Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. New research has now identified a unique subclass of these compounds, dubbed geroneuroprotectors (GNPs), which are AD drug candidates and slow the aging process in mice.READ MORE